Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational study.

Saved in:
Bibliographic Details
Title: Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational study.
Authors: Green JR; Gastroenterology Unit, City General Hospital, Stoke-on-Trent, UK. Jonathan.Green@uhns.nhs.uk, Swan CH, Gibson JA, Kerr GD, Swarbrick ET, Thornton PC
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2004 Feb 15; Vol. 19 (4), pp. 435-42.
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Print ISSN: 0269-2813 (Print) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:0269-2813
DOI:10.1111/j.1365-2036.2004.01866.x